Clinical Trial Update: Familiarization and Safety Study of PB127 Ultrasound Contrast Agent [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update noting completion of Phase 2/Phase 3 studies evaluating PB127 Ultrasound Contrast Agent for coronary artery disease, focusing on familiari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PB127 Ultrasound Contrast Agent

Snippet

Sponsor: Point Biomedical | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED